Stagezero Life Sciences PE Ratio 2012-2024 | SZLSF
Current and historical p/e ratio for Stagezero Life Sciences (SZLSF) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Stagezero Life Sciences PE ratio as of June 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Stagezero Life Sciences PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-30 | 0.00 | 0.00 | |
| 2024-09-30 | 0.04 | 0 | 0.00 |
| 2024-06-30 | 0.00 | $-0.01 | 0.00 |
| 2024-03-31 | 0.04 | $-0.01 | 0.00 |
| 2023-12-31 | 0.03 | $-0.03 | 0.00 |
| 2023-09-30 | 0.04 | $-0.12 | 0.00 |
| 2023-06-30 | 0.05 | $-0.11 | 0.00 |
| 2023-03-31 | 0.07 | $-0.12 | 0.00 |
| 2022-12-31 | 0.04 | $-0.11 | 0.00 |
| 2022-09-30 | 0.06 | $-0.07 | 0.00 |
| 2022-06-30 | 0.06 | $-0.09 | 0.00 |
| 2022-03-31 | 0.14 | $-0.03 | 0.00 |
| 2021-12-31 | 0.23 | $-0.10 | 0.00 |
| 2021-09-30 | 0.30 | $-0.07 | 0.00 |
| 2021-06-30 | 0.38 | $-0.23 | 0.00 |
| 2021-03-31 | 1.25 | $-0.28 | 0.00 |
| 2020-12-31 | 0.58 | $-0.28 | 0.00 |
| 2020-09-30 | 0.62 | $-0.26 | 0.00 |
| 2020-06-30 | 0.36 | 0 | 0.00 |
| 2020-03-31 | 0.44 | 0 | 0.00 |
| 2019-12-31 | 0.03 | $-0.32 | 0.00 |
| 2019-09-30 | 0.06 | $-0.32 | 0.00 |
| 2019-06-30 | 0.14 | $-0.48 | 0.00 |
| 2019-03-31 | 0.14 | $-0.64 | 0.00 |
| 2018-12-31 | 0.04 | $-0.24 | 0.00 |
| 2018-09-30 | 0.05 | $-0.24 | 0.00 |
| 2018-06-30 | 0.05 | $-0.24 | 0.00 |
| 2018-03-31 | 0.09 | $-0.16 | 0.00 |
| 2017-12-31 | 0.16 | $-0.32 | 0.00 |
| 2017-09-30 | 0.08 | $-0.16 | 0.00 |
| 2017-06-30 | 0.15 | $-0.40 | 0.00 |
| 2017-03-31 | 0.28 | $-0.48 | 0.00 |
| 2016-12-31 | 0.23 | $-0.72 | 0.00 |
| 2016-09-30 | 0.25 | $-1.04 | 0.00 |
| 2016-06-30 | 0.15 | $-0.72 | 0.00 |
| 2016-03-31 | 0.12 | $-0.56 | 0.00 |
| 2015-12-31 | 0.02 | $-0.32 | 0.00 |
| 2015-09-30 | 0.22 | $-0.40 | 0.00 |
| 2015-06-30 | 0.29 | $-0.56 | 0.00 |
| 2015-03-31 | 0.59 | $-1.04 | 0.00 |
| 2014-12-31 | 1.56 | $-1.20 | 0.00 |
| 2014-09-30 | 1.17 | $-1.44 | 0.00 |
| 2014-06-30 | 1.11 | $-2.08 | 0.00 |
| 2014-03-31 | 1.29 | $-2.08 | 0.00 |
| 2013-12-31 | 0.78 | $-2.16 | 0.00 |
| 2013-09-30 | 0.39 | $-2.32 | 0.00 |
| 2013-06-30 | 0.89 | $-1.60 | 0.00 |
| 2013-03-31 | 0.83 | $-1.20 | 0.00 |
| 2012-12-31 | 0.65 | $-0.88 | 0.00 |
| 2012-09-30 | 0.76 | $-0.32 | 0.00 |
| 2012-06-30 | 0.85 | $-0.24 | 0.00 |
| 2012-03-31 | 0.92 | $-0.16 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.004B |
| StageZero Life Sciences Ltd is dedicated to the early detection of cancer and multiple disease states through whole blood. The company's test consists of Aristotle(R), a multi-cancer panel for simultaneously screening for cancers from a single sample of blood. StageZero Life Sciences Ltd, formerly known as GeneNews Ltd., is based in TORONTO, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |